Australia's largest stock trading and investment forum Australia's #1 stock forum

NEU neuren pharmaceuticals limited

6.69%

$14.20

NEU is materially undervalued, page-50

First 50 Last

Share
Profile

Follow
nashezz

2,750 Posts.

1051

12/08/24

16:36

Post #: 75172302
Share

Originally posted by Tony barber ↑

Great. When did they apply?
The EU really doesnt care about FDA approval. What's the status with Acadia? Have they even applied?

TLX (for example) applied. And in the last week before a decision had to be made one country asked a question that required a withdraw of the application.

It's been 3 years now. Maybe more actually.

Expand

You is the one putting some easily disproved information out there. Why don't you tell us when they applied and how long it took?

In the meantime

https://www.ema.europa.eu/en/human-...-authorisation/evaluation-medicines-step-step

NEU Price at posting: $16.23 Sentiment: Buy Disclosure: Held
16 Upvote

3 Great analysis

Reply

Top Stories

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

First 50 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $14.20		Change 0.890(6.69%)		Mkt cap ! $1.761B

Open	High	Low	Value	Volume
$13.50	$14.26	$12.96	$9.111M	655.8K

Buyers (Bids)

No.	Vol.	Price($)
1	2000	$14.17

Sellers (Offers)

Price($)	Vol.	No.
$14.23	3278	1

View Market Depth

No.	Vol.	Price($)
1	1300	14.030
1	500	14.000
1	357	13.970
1	30	13.900
1	700	13.700

Price($)	Vol.	No.
14.260	2920	1
14.300	1000	1
14.380	72	1
14.400	1000	1
14.460	434	1

Last trade - 16.15pm 27/06/2025 (20 minute delay)

NEU (ASX) Chart

NEU is materially undervalued, page-50

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

NEU is materially undervalued, page-50

Top Stories

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News